Update

The Global Fund Joins Partners in Committing to Address Large Shortfalls in Oxygen

Opportunity for Evaluation of Diagnostic Products – Syphilis Diagnosis

New Isoniazid/rifapentine and rifapentine generic for tuberculosis (TB) prevention recently recommended for use by ERP

External Quality Assessment: Highest Possible Results for OIG Audit and Investigation Units

Global Fund Appoints Susie Rhee as General Counsel and Head of the Legal & Governance Department

Opportunity for Evaluation of Diagnostic Products

Message from the Executive Director: Global Fund Grants in Liberia

Liberia: Fraudulent and Abusive Practices in Global Fund Programs

Message from the Executive Director: Global Fund Grants in Nigeria

Virtual Press Briefing: A Strategy to Manage Long-Term Risks of COVID-19

Audit of the COVID-19 Response Mechanism 2021

Data Science Catalytic Fund - Improving Collection and Use of Community Health Data